A detailed history of S Bank Fund Management LTD transactions in Moderna, Inc. stock. As of the latest transaction made, S Bank Fund Management LTD holds 885 shares of MRNA stock, worth $22,744. This represents 0.0% of its overall portfolio holdings.

Number of Shares
885
Holding current value
$22,744
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$28.35 - $47.53 $25,089 - $42,064
885 New
885 $25.1 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $10.1B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track S Bank Fund Management LTD Portfolio

Follow S Bank Fund Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of S Bank Fund Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on S Bank Fund Management LTD with notifications on news.